Aromasin And Breast Cancer Treatment Drugs

Studies of women who have successfully switched from tamoxifen to Aromasin have a thirty-one percent lower risk of recurrence of cancer of the breast. This is a significant number and should be examined carefully for the benefits of switching from tamoxifen.

Another outstanding number is there were sixty-eight percent fewer cases of cancer developing in the healthy breast after staying on tamoxifen for two to three years and then switching to Aromasin. Breaking these statistics down for numbers that are easier to understand means there was a difference of over 70 women who did not experience a recurrence of their cancer after taking Aromasin.

Unlike other drugs that are being studied and used in clinical trials, Aromasin was designed for women who have advanced stages of breast cancer. It has proven effective in early stage breast cancer for those women who have hormone receptive cancer. Aromasin is to be used after an early period of taking the drug tamoxifen and women who have already gone through menopause.

Read the full article here: Breast Cancer Treatment